A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study
Titel:
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study
Auteur:
Chao, Joseph Synold, Timothy W. Morgan, Robert J. Kunos, Charles Longmate, Jeff Lenz, Heinz-Josef Lim, Dean Shibata, Stephen Chung, Vincent Stoller, Ronald G. Belani, Chandra P. Gandara, David R. McNamara, Mark Gitlitz, Barbara J. Lau, Derick H. Ramalingam, Suresh S. Davies, Angela Espinoza-Delgado, Igor Newman, Edward M. Yen, Yun